Positive percentage of p-Akt and any positive of p-Akt, p-mTOR and p-eIF4E proteins expression were positively associated with clinical stages of NSCLC patients (P = 0.023, P = 0.035, respectively). Here, MTOR is linked to non-small cell lung carcinoma.